William Blair
http://www.williamblair.comWilliam Blair & Company, L.L.C. is a Chicago-based investment firm offering investment banking, asset management, equity research, institutional and private brokerage, and private capital to individual, institutional, and issuing clients. Since 1935, it has been committed to helping clients achieve their financial objectives.
View Older Stories View More Recent Stories
-
William Blair Reiterates Outperform Rating on Exact Sciences (EXAS)
-
William Blair Reiterates Outperform Rating on Apellis Pharmaceuticals (APLS)
-
William Blair Reiterates Outperform Rating on Costco Wholesale (COST)
-
Vertical Aerospace prices $60 million public offering at $5 per share
-
Vertical Aerospace Announces Pricing of Underwritten Public Offering
-
William Blair on Centrus Energy Corp. (LEU): 'we estimate a bull case fair value of $246 per share'
-
William Blair Starts Wingstop (WING) at Outperform
-
Vertical Aerospace launches $60 million public stock offering
-
Vertical Aerospace Announces Launch of Proposed Underwritten Public Offering
-
William Blair Names Global Head of Investment Management
-
Schwab Grows Institutional No Transaction Fee Fund Offering for Independent Advisors
-
Enovix (ENVX) Declares Shareholder Warrant Dividend
-
Enovix Declares Shareholder Warrant Dividend
-
NetApp and William Blair & Company to Host a Tech Talk on Intelligent Data Infrastructure for AI
-
Merit Financial Advisors Announces New Minority Investment Partner, Fueling Next Chapter of Expansion
-
William Blair Downgrades Jasper Therapeutics (JSPR) to Market Perform
-
William Blair Downgrades WNS Limited (WNS) to Market Perform After Takeover
-
William Blair Reiterates Outperform Rating on Denali Therapeutics Inc. (DNLI) 'Remains undervalued and de-risked'
-
William Blair Reiterates Outperform Rating on Karman Holdings Inc (KRMN)
-
William Blair Reiterates Outperform Rating on LENZ Therapeutics Inc (LENZ) 'We see a potential blockbuster opportunity for LNZ100'
-
William Blair Starts Chime Financial (CHYM) at Outperform
-
William Blair Upgrades CACI International (CACI) to Outperform
-
William Blair Downgrades Tesla (TSLA) to Market Perform
-
Centrus Energy to Participate in Upcoming Investor Events
-
William Blair Reiterates Outperform Rating on Tesla (TSLA) 'Deliveries better than feared'
-
William Blair Reiterates Outperform Rating on BrightView Holdings (BV)
-
William Blair Reiterates Outperform Rating on American Express (AXP)
-
William Blair Starts Dianthus Therapeutics (DNTH) at Outperform
-
AeroVironment, Inc. Announces Pricing of Upsized Offerings of Common Stock And 0% Convertible Senior Notes Due 2030
-
William Blair Reiterates Outperform Rating on Apellis Pharmaceuticals (APLS)
-
William Blair Reiterates Outperform Rating on Oracle (ORCL) 'Contines to have a sticky install base and high mindshare'
-
Harris Williams Expands Frankfurt Office with Additions of Managing Directors Philipp Mohr and Mark Brune
-
William Blair Reiterates Market Perform Rating on Moderna (MRNA) 'Competition in the space and waning vaccine sentiment are negatively impacting the base business'
-
William Blair Reiterates Outperform Rating on Amgen (AMGN)
-
William Blair Reiterates Outperform Rating on ServiceTitan (TTAN)
-
NIQ Global Intelligence (NIQ) files S-1 with SEC for proposed IPO
-
NIQ Announces Filing of Registration Statement for Proposed Initial Public Offering
-
McGraw Hill Announces Filing of Registration Statement for Proposed Initial Public Offering
-
William Blair Reiterates Market Perform Rating on Lindsay Corporation (LNN) 'We expect earnings to contract next year'
-
William Blair Reiterates Outperform Rating on Genpact Ltd. (G)
-
FDA removing REMS from several CAR-T cell therapies positive for these 3 stocks - William Blair
-
Form D/A William Blair Emerging
-
Form D/A William Blair Emerging
-
Form D/A William Blair Internatio
-
Form D/A William Blair Internatio
-
William Blair Starts James Hardie Industries (JHX) at Outperform
-
William Blair Reiterates Outperform Rating on Alto Neuroscience (ANRO)
-
William Blair Reiterates Outperform Rating on AeroVironment (AVAV)
-
William Blair Reiterates Outperform Rating on Acuity Brands (AYI) 'Are 50% gross margins sustainable? We believe yes'
-
William Blair Comments on Incyte (INCY) CEO Transition

